Erlotinib Versus Gemcitabine/Cisplatin as (Neo)Adjuvant Treatment in Non-small Cell Lung Cancer
Clinical trial NCT01407822 · UNKNOWN
Trial details
- NCT number
- NCT01407822
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-05
- Primary completion
- 2018-04-24
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.